Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice.

Behavioral abnormalities Dopaminergic neurons Lewy bodies Parkinson's disease Propagation Transgenic mouse α-Synuclein

Journal

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
ISSN: 1878-7479
Titre abrégé: Neurotherapeutics
Pays: United States
ID NLM: 101290381

Informations de publication

Date de publication:
Jan 2022
Historique:
accepted: 27 11 2021
medline: 1 1 2022
pubmed: 1 1 2022
entrez: 4 1 2024
Statut: ppublish

Résumé

Parkinson's disease (PD), the most common neurodegenerative movement disorder, is characterized by dopaminergic neuron loss in the substantia nigra pars compacta (SNpc) and intraneuronal α-synuclein (α-syn) inclusions. It is highly needed to establish a rodent model that recapitulates the clinicopathological features of PD within a short period to efficiently investigate the pathological mechanisms and test disease-modifying therapies. To this end, we analyzed three mouse lines, i.e., wild-type mice, wild-type human α-syn bacterial artificial chromosome (BAC) transgenic (BAC-SNCA Tg) mice, and A53T human α-syn BAC transgenic (A53T BAC-SNCA Tg) mice, receiving dorsal striatum injections of human and mouse α-syn preformed fibrils (hPFFs and mPFFs, respectively). mPFF injections induced more severe α-syn pathology in most brain regions, including the ipsilateral SNpc, than hPFF injections in all genotypes at 1-month post-injection. Although these Tg mouse lines expressed a comparable amount of α-syn in the brains, the mPFF-injected A53T BAC-SNCA Tg mice exhibited the most severe α-syn pathology as early as 0.5-month post-injection. The mPFF-injected A53T BAC-SNCA Tg mice showed a 38% reduction in tyrosine hydroxylase (TH)-positive neurons in the ipsilateral SNpc, apomorphine-induced rotational behavior, and motor dysfunction at 2 months post-injection. These data indicate that the extent of α-syn pathology induced by α-syn PFF injection depends on the types of α-syn PFFs and exogenously expressed α-syn in Tg mice. The mPFF-injected A53T BAC-SNCA Tg mice recapitulate the key features of PD more rapidly than previously reported mouse models, suggesting their usefulness for testing disease-modifying therapies as well as analyzing the pathological mechanisms.

Identifiants

pubmed: 38176797
pii: S1878-7479(23)00168-X
doi: 10.1007/s13311-021-01169-5
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

289-304

Informations de copyright

Copyright © 2022 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier Inc. All rights reserved.

Auteurs

Shinya Okuda (S)

Department of Neurology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, 606-8507, Sakyoku, Kyoto, Japan.

Norihito Uemura (N)

Department of Neurology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, 606-8507, Sakyoku, Kyoto, Japan; Department of Pathology and Laboratory Medicine, Institute On Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, 19104-2676, Philadelphia, PA, USA. Electronic address: nuemura@kuhp.kyoto-u.ac.jp.

Masanori Sawamura (M)

Department of Neurology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, 606-8507, Sakyoku, Kyoto, Japan.

Tomoyuki Taguchi (T)

Department of Neurology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, 606-8507, Sakyoku, Kyoto, Japan.

Masashi Ikuno (M)

Department of Neurology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, 606-8507, Sakyoku, Kyoto, Japan.

Maiko T Uemura (MT)

Department of Neurology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, 606-8507, Sakyoku, Kyoto, Japan; Department of Pathology and Laboratory Medicine, Institute On Aging and Center for Neurodegenerative Disease Research, University of Pennsylvania School of Medicine, 19104-2676, Philadelphia, PA, USA.

Hodaka Yamakado (H)

Department of Neurology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, 606-8507, Sakyoku, Kyoto, Japan.

Ryosuke Takahashi (R)

Department of Neurology, Kyoto University Graduate School of Medicine, 54 Shogoin-Kawaharacho, 606-8507, Sakyoku, Kyoto, Japan. Electronic address: ryosuket@kuhp.kyoto-u.ac.jp.

Classifications MeSH